Clinical Trial Update: Resveratrol: A Potential Anti- Remodeling Agent in Heart Failure, From Bench to Bedside [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating resveratrol as a potential anti-remodeling agent in heart failure due to dilated cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: St. Boniface Hospital | Conditions: Dilated Cardiomyopathy | Phase 3 | Status: UNKNOWN